![](/img/cover-not-exists.png)
An early clinical trial of Salirasib, an oral RAS inhibitor, in Japanese patients with relapsed/refractory solid tumors
Furuse, Junji, Kurata, Takayasu, Okano, Naohiro, Fujisaka, Yasuhito, Naruge, Daisuke, Shimizu, Toshio, Kitamura, Hiroshi, Iwasa, Tsutomu, Nagashima, Fumio, Nakagawa, KazuhikoLanguage:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-018-3618-4
Date:
July, 2018
File:
PDF, 903 KB
english, 2018